Biocryst Pharmaceuticals Inc (BCRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)

BCRX 7.030

-1.8%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Doc Bones	7/10/2007 5:07:19 PM
	Read Replies (1) of 269

XL Capital and Integra LifeSciences Upgraded, BioCryst Pharmaceuticals Downgraded Tuesday July 10, 9:55 am ET By TradingMarkets Research [snip] BioCryst Pharmaceuticals (NasdaqGM:BCRX) was downgraded to 2, from 3. The biotech company's shares jumped 7.16% yesterday after reaching an agreement with the FDA for the for the trial of oral Fodosine. BCRX shares have lost more than -30% this year, after losing -31% in 2006. PowerRatings (for Investors) are courtesy of PowerRatings.net. ADVERTISEMENT biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next